Legal5 Nov 2026, 09:32 pm
AstraZeneca Pharma India expects ₹70.8M improvement charges
AI Summary
AstraZeneca Pharma India Ltd has intimated that it may receive a revised demand notice from Bengaluru North City Corporation or Greater Bengaluru Authority for improvement charges and applicable interest, likely under the Greater Bengaluru Governance Act, 2024. The company anticipates the charges to not exceed INR 70.8 million, with additional applicable interest. AstraZeneca has already made a provision of INR 156.1 million in its books based on estimates. The company will examine the demand and take appropriate action.
Key Highlights
- AstraZeneca Pharma India anticipates a revised demand notice for improvement charges.
- The estimated charges are up to INR 70.8 million, plus interest.
- The company has already provisioned INR 156.1 million.
- The notice is related to the Greater Bengaluru Governance Act, 2024.
Price Impact
More from ASTRAZEN